Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802.

Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802. Blood Adv. 2018 08 14; 2(15):1882-1888.

View in: PubMed

subject areas

Adolescent
Adult
Amphiregulin
Disease-Free Survival
Female
Graft vs Host Disease
Humans
Male
Middle Aged
Minnesota
Risk Assessment
Severity of Illness Index
Survival Rate

authors with profiles

AMIN MAJID ALOUSI